Nabi Biopharmaceuticals Adopts Plan to Preserve Valuable Net Operating Losses

ROCKVILLE, Md., Aug. 25, 2011 (GLOBE NEWSWIRE) -- Nabi Biopharmaceuticals (Nasdaq:NABI) today announced that its Board of Directors adopted a stockholder Rights Agreement designed to preserve its substantial net operating loss (NOL) tax assets.